• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较宏蛋白质组学分析显示,重度抑郁症患者的粪便微生物群特征发生了改变。

Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder.

作者信息

Chen Zhi, Li Jie, Gui Siwen, Zhou Chanjuan, Chen Jianjun, Yang Chuangchuang, Hu Zicheng, Wang Haiyang, Zhong Xiaogang, Zeng Li, Chen Ke, Li Pengfei, Xie Peng

机构信息

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University.

Chongqing Key Laboratory of Neurobiology.

出版信息

Neuroreport. 2018 Mar 21;29(5):417-425. doi: 10.1097/WNR.0000000000000985.

DOI:10.1097/WNR.0000000000000985
PMID:29432299
Abstract

Major depressive disorder (MDD) is a highly prevalent and debilitating mental illness, which is associated with disorder of gut microbiota. However, few studies focusing on detection of the signatures of bacteria in feces of MDD patients using proteomics approach have been carried out. Here, a comparative metaproteomics analysis on the basis of an isobaric tag for relative and absolute quantification coupled with tandem mass spectrometry was carried out to explore the signature of gut microbiota in patients with MDD. Ten patients (age: 18-56 years, five women) who had MDD and a score over 20 on the Hamilton's Depression Scale and 10 healthy controls (age: 24-65 years, five women) group matched for sex, age, and BMI were enrolled. As a result, 279 significantly differentiated bacterial proteins (P<0.05) were detected and used for further bioinformatic analysis. According to phylogenetic analysis, statistically significant differences were observed for four phyla: Bacteroidetes, Proteobacteria, Firmicutes, Actinobacteria (P<0.05, for each). Abundances of 16 bacterial families were significantly different between the MDD and healthy controls (P<0.05). Furthermore, Cluster of Orthologous Groups analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that disordered metabolic pathways of bacterial proteins were mainly involved in glucose metabolism and amino acid metabolism. In conclusion, fecal microbiota signatures were altered significantly in MDD patients. Our findings provide a novel insight into the potential connection between gut microbiota and depression.

摘要

重度抑郁症(MDD)是一种高度流行且使人衰弱的精神疾病,与肠道微生物群紊乱有关。然而,很少有研究使用蛋白质组学方法来检测MDD患者粪便中的细菌特征。在此,我们基于相对和绝对定量的等压标签结合串联质谱进行了一项比较性宏蛋白质组学分析,以探索MDD患者肠道微生物群的特征。招募了10名患有MDD且汉密尔顿抑郁量表得分超过20分的患者(年龄:18 - 56岁,5名女性)以及10名在性别、年龄和BMI方面匹配的健康对照者(年龄:24 - 65岁,5名女性)。结果,检测到279种显著差异的细菌蛋白(P<0.05),并用于进一步的生物信息学分析。根据系统发育分析,观察到四个门存在统计学显著差异:拟杆菌门、变形菌门、厚壁菌门、放线菌门(每个门P<0.05)。MDD患者与健康对照者之间16个细菌家族的丰度存在显著差异(P<0.05)。此外,直系同源簇分析和京都基因与基因组百科全书通路分析表明,细菌蛋白的代谢途径紊乱主要涉及葡萄糖代谢和氨基酸代谢。总之,MDD患者的粪便微生物群特征发生了显著改变。我们的研究结果为肠道微生物群与抑郁症之间的潜在联系提供了新见解。

相似文献

1
Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder.比较宏蛋白质组学分析显示,重度抑郁症患者的粪便微生物群特征发生了改变。
Neuroreport. 2018 Mar 21;29(5):417-425. doi: 10.1097/WNR.0000000000000985.
2
Altered fecal microbiota composition in patients with major depressive disorder.重度抑郁症患者粪便微生物群落组成的改变。
Brain Behav Immun. 2015 Aug;48:186-94. doi: 10.1016/j.bbi.2015.03.016. Epub 2015 Apr 13.
3
Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients.同样在抑郁症中,肠道微生物群的细微差别:来自一项针对重度抑郁症与双相情感障碍伴当前重度抑郁发作患者的宏基因组测序研究的证据。
J Psychiatr Res. 2019 Jun;113:90-99. doi: 10.1016/j.jpsychires.2019.03.017. Epub 2019 Mar 21.
4
Association between major depressive disorder and gut microbiota dysbiosis.重度抑郁症与肠道菌群失调的关联。
Int J Psychiatry Med. 2024 Nov;59(6):702-710. doi: 10.1177/00912174241266646. Epub 2024 Jul 22.
5
Age-specific differential changes on gut microbiota composition in patients with major depressive disorder.特定年龄段的抑郁症患者肠道微生物群落组成的差异变化。
Aging (Albany NY). 2020 Feb 10;12(3):2764-2776. doi: 10.18632/aging.102775.
6
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.肠道微生物组重塑通过宿主代谢介导的途径诱导抑郁样行为。
Mol Psychiatry. 2016 Jun;21(6):786-96. doi: 10.1038/mp.2016.44. Epub 2016 Apr 12.
7
Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers.粪便微生物移植小鼠肝脏中的代谢产物鉴定和慢性不可预测轻度应激小鼠肝脏的蛋白质组学结合研究。
Transl Psychiatry. 2018 Jan 31;8(1):34. doi: 10.1038/s41398-017-0078-2.
8
Exploration of microbiota targets for major depressive disorder and mood related traits.探索与重度抑郁症和情绪相关特征相关的微生物组靶标。
J Psychiatr Res. 2019 Apr;111:74-82. doi: 10.1016/j.jpsychires.2019.01.016. Epub 2019 Jan 19.
9
Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder.首发未治疗的重度抑郁症患者肠道菌群特征及其与 hs-CRP 和躯体症状的相关性。
J Affect Disord. 2024 Jul 1;356:664-671. doi: 10.1016/j.jad.2024.04.011. Epub 2024 Apr 12.
10
Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.基于基因组的宏蛋白质组学分析揭示了早产儿肠道微生物群发育的特征,表明在生命早期存在特定物种的代谢转变和变异性。
Microbiome. 2017 Jul 10;5(1):72. doi: 10.1186/s40168-017-0290-6.

引用本文的文献

1
Early-life gut microbiome development and its potential long-term impact on health outcomes.早期肠道微生物群的发育及其对健康结果的潜在长期影响。
Microbiome Res Rep. 2025 Apr 17;4(2):20. doi: 10.20517/mrr.2024.78. eCollection 2025.
2
Gut microbiota in anxiety and depression: mechanisms, drug interactions, and therapeutic implications.焦虑和抑郁中的肠道微生物群:机制、药物相互作用及治疗意义。
Pharmacol Rep. 2025 Jul 14. doi: 10.1007/s43440-025-00759-w.
3
Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets.
重度抑郁症、双相情感障碍和精神分裂症中的外周免疫炎症途径:探索其作为治疗靶点的潜力
CNS Drugs. 2025 Jun 13. doi: 10.1007/s40263-025-01195-3.
4
Modulating Gut Microbiota with Dietary Components: A Novel Strategy for Cancer-Depression Comorbidity Management.利用膳食成分调节肠道微生物群:癌症-抑郁症共病管理的新策略。
Nutrients. 2025 Apr 29;17(9):1505. doi: 10.3390/nu17091505.
5
Depressive symptoms at short-, medium-, and long-term follow-up after bariatric surgical procedures: A systematic review and meta-analysis.减肥手术后短期、中期和长期随访时的抑郁症状:一项系统评价和荟萃分析。
Obes Rev. 2025 Aug;26(8):e13927. doi: 10.1111/obr.13927. Epub 2025 Apr 13.
6
Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease.肠道微生物群:预防和治疗神经精神疾病的新窗口。
J Cent Nerv Syst Dis. 2025 Feb 21;17:11795735251322450. doi: 10.1177/11795735251322450. eCollection 2025.
7
Advances in multi-omics integrated analysis methods based on the gut microbiome and their applications.基于肠道微生物群的多组学综合分析方法进展及其应用
Front Microbiol. 2025 Jan 3;15:1509117. doi: 10.3389/fmicb.2024.1509117. eCollection 2024.
8
Gut microbiota dysbiosis-mediated ceramides elevation contributes to corticosterone-induced depression by impairing mitochondrial function.肠道微生物群落失调介导的神经酰胺升高通过损害线粒体功能导致皮质酮诱导的抑郁。
NPJ Biofilms Microbiomes. 2024 Oct 28;10(1):111. doi: 10.1038/s41522-024-00582-w.
9
Cutting-Edge iPSC-Based Approaches in Studying Host-Microbe Interactions in Neuropsychiatric Disorders.基于 iPSC 的前沿方法研究神经精神疾病中的宿主-微生物相互作用。
Int J Mol Sci. 2024 Sep 21;25(18):10156. doi: 10.3390/ijms251810156.
10
Exploring the Potential of Probiotics and Prebiotics in Major Depression: From Molecular Function to Clinical Therapy.探讨益生菌和益生元在重度抑郁症中的潜力:从分子功能到临床治疗。
Probiotics Antimicrob Proteins. 2024 Dec;16(6):2181-2217. doi: 10.1007/s12602-024-10326-z. Epub 2024 Jul 30.